2025. The benefits of immunotherapy and the impact of available therapies for metastatic melanoma on the clinical outcome of patients in the Unified Health System (SUS). Research, Society and Development. 14, 5 (May 2025), e5014548809. DOI:https://doi.org/10.33448/rsd-v14i5.48809.